Effect of Drakshadileha in cough

Clinical Study To Evaluate The Efficacy of Drakshadileha in Kasa

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/06/026128

Enrollment

144

Registered

2020-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Clinical Study To Evaluate The Efficacy of Drakshadileha in Kasa: Total dose will be given in 3 divided dose with honey. Control Intervention1: Clinical Study To Evaluate The Efficacy o

Eligibility

Inclusion criteria

Inclusion criteria: Age more than1 year & less than16 year (M/F both) cough without sputum

Exclusion criteria

Exclusion criteria: 1.Age less than 1 year & more than 16 year. 2.Cough associated with other Respiratory disorder like Bronchial Asthama, Tuberculosis, Pulmonary Eosinophillia, Loffler syndrome,Whooping cough or any other systemic diseases. 3.Cough associated with severe malnutrition. 4.Cough associated with neurological disorders.

Design outcomes

Primary

Measure	Time frame
assessment of kasa will be done on based of labouratory on investigations and degradation of symptomsTimepoint: 2 months	—

Secondary

Measure	Time frame
assessment of kasa will be done on based of labouratory on investigations and degradation of symptomsTimepoint: 2 months	—

Countries

India

Contacts

Public ContactProf Dr Keerti Verma

Rishikul Campus, Uttarakhand Ayurved University

keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026